ReviewCancerPublished
Adjuvant CDK4/6 inhibitors in early-stage breast cancer: Clinical evidence and considerations for risk stratification and treatment selection
Regional connection
Verified An author affiliation on the Europe PMC record names Fox Chase Cancer Center, with Temple Health linked by the institution reference. Affiliation source
- Institutions
- Fox Chase Cancer Center, Temple Health
- County
- Philadelphia County
Publication record
- Type
- Review
- Venue
- Cancer
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Breast Neoplasms; Neoplasm Recurrence, Local; Aminopyridines; Piperazines; Benzimidazoles; Purines; Protein Kinase Inhibitors; Neoplasm Staging; Chemotherapy, Adjuvant; Risk Assessment; Female
- PubMed ID
- 42667265
- PubMed Central ID
- PMC13525749
- Open access
- Yes, free to read
- Added to directory
- Source checked